VeriChip presents RFID Infant Protection products
Health pros are getting hi-tech to protect every aspect of their patients’ lives.
As such, VeriChip will be touting its RFID-based infant protection solutions at the Association of Women’s Health, Obstetric and Neonatal Nurses Convention trade show in Baltimore, this weekend and early next week. Among the goodies at the VeriChip booth this year: demonstrations of both the HALO and Hugs system, and showcasing of HALO’s patented skin-sensing technology (to prevent tag removal, and Hugs’ array of productivity enhancing options).
The conference comprises a gathering of nurses, nurse practitioners and nurse executives in the field of maternal/child care. It represents an opportunity to reach more than 2,000 healthcare professionals.
VeriChip Corporation to Present Its RFID Infant Protection Solutions at AHWONN 2006 in Baltimore This Weekend
BALTIMORE –(Business Wire)– June 23, 2006 – VeriChip Corporation, a subsidiary of Applied Digital (NASDAQ: ADSX), will present its RFID infant protection solutions at the AWHONN (Association of Women’s Health, Obstetric and Neonatal Nurses) Convention trade show in Baltimore, MD this weekend and early next week.
The AWHONN Convention is a gathering of nurses, nurse practitioners and nurse executives in the field of maternal/child care. It represents an opportunity to reach more than 2,000 healthcare professionals.
The VeriChip booth at this year’s AWHONN Convention features live demonstrations of both the HALO and Hugs system, giving Convention delegates the opportunity to see such features as HALO’s patented skin-sensing technology to prevent tag removal, and Hugs’ array of productivity enhancing options.
Kevin McLaughlin, Chief Executive Officer of VeriChip, commented: “The number of current customers who drop by the booth is a great testament to our strong reputation in the marketplace, and the best advertising to be had.”
For more information on the HALO or Hugs systems, please contact 1-866-559-6275 or email [email protected]. Additional information can be found online at www.verichipcorp.com.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip’s goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System which is used to rapidly and accurately identify people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.
About Applied Digital – “The Power of Identification Technology”
Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The Company’s unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as the leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (AMEX: DOC).
Statements about the Company’s future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company’s actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
